Skip to search formSkip to main contentSkip to account menu

SWOG

Known as: Southwest Oncology Group 
An NCI-sponsored cooperative group, an adult cancer clinical trials organization, one of the largest in the world. The group was established in 1956… 
National Institutes of Health

Related topics

Related topics

1 relation
Source of protocol in which patient enrolled:Type:Pt:Cancer.XXX:Nom

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).
PURPOSE To determine the predictive and prognostic value of the consensus molecular subtypes (CMSs) of colorectal cancer (CRC… 
Highly Cited
2014
Highly Cited
2014
CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt…
LBA3 Background: Irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6), combined with bevacizumab (BV… 
Highly Cited
2014
Highly Cited
2014
Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).
All cases of clinical myeloma (CMM) are preceded by an asymptomatic monoclonal gammopathy (AMG), classified as either monoclonal… 
Highly Cited
2010
Highly Cited
2010
Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy.
Highly Cited
2007
Highly Cited
2007
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.
PURPOSE Southwest Oncology Group (SWOG) trial 8794 demonstrated that adjuvant radiation reduces the risk of biochemical (prostate… 
Highly Cited
2006
Highly Cited
2006
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
BACKGROUND The identification of surrogate endpoints that can replace true outcome endpoints is crucial to the rapid evaluation… 
Highly Cited
2003
Highly Cited
2003
Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast…
Highly Cited
2003
Highly Cited
2003
First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy.
Highly Cited
2002
Highly Cited
2002
Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment
BackgroundIntergroup 0116 (Southwest Oncology Group 9008), a national, multicenter, two-armed, prospective, randomized trial of… 
Highly Cited
1992
Highly Cited
1992
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
PURPOSE The Southwest Oncology Group (SWOG) conducted a randomized comparison of cisplatin plus fluorouracil (5-FU) and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)